523 related articles for article (PubMed ID: 31985807)
1. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.
Chou ST; Alsawas M; Fasano RM; Field JJ; Hendrickson JE; Howard J; Kameka M; Kwiatkowski JL; Pirenne F; Shi PA; Stowell SR; Thein SL; Westhoff CM; Wong TE; Akl EA
Blood Adv; 2020 Jan; 4(2):327-355. PubMed ID: 31985807
[TBL] [Abstract][Full Text] [Related]
2. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
3. Transfusion therapy for sickle cell disease: a balancing act.
Chou ST
Hematology Am Soc Hematol Educ Program; 2013; 2013():439-46. PubMed ID: 24319217
[TBL] [Abstract][Full Text] [Related]
4. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.
Liem RI; Lanzkron S; D Coates T; DeCastro L; Desai AA; Ataga KI; Cohen RT; Haynes J; Osunkwo I; Lebensburger JD; Lash JP; Wun T; Verhovsek M; Ontala E; Blaylark R; Alahdab F; Katabi A; Mustafa RA
Blood Adv; 2019 Dec; 3(23):3867-3897. PubMed ID: 31794601
[TBL] [Abstract][Full Text] [Related]
5. How to avoid the problem of erythrocyte alloimmunization in sickle cell disease.
Pirenne F; Floch A; Habibi A
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):689-695. PubMed ID: 34889373
[TBL] [Abstract][Full Text] [Related]
6. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.
Brandow AM; Carroll CP; Creary S; Edwards-Elliott R; Glassberg J; Hurley RW; Kutlar A; Seisa M; Stinson J; Strouse JJ; Yusuf F; Zempsky W; Lang E
Blood Adv; 2020 Jun; 4(12):2656-2701. PubMed ID: 32559294
[TBL] [Abstract][Full Text] [Related]
7. American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.
Kanter J; Liem RI; Bernaudin F; Bolaños-Meade J; Fitzhugh CD; Hankins JS; Murad MH; Panepinto JA; Rondelli D; Shenoy S; Wagner J; Walters MC; Woolford T; Meerpohl JJ; Tisdale J
Blood Adv; 2021 Sep; 5(18):3668-3689. PubMed ID: 34581773
[TBL] [Abstract][Full Text] [Related]
8. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
Coleman S; Westhoff CM; Friedman DF; Chou ST
Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
[TBL] [Abstract][Full Text] [Related]
9. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
Pirenne F; Yazdanbakhsh K
Blood; 2018 Jun; 131(25):2773-2781. PubMed ID: 29724898
[TBL] [Abstract][Full Text] [Related]
10. Management of Patients with Sickle Cell Disease Using Transfusion Therapy: Guidelines and Complications.
Chou ST; Fasano RM
Hematol Oncol Clin North Am; 2016 Jun; 30(3):591-608. PubMed ID: 27112998
[TBL] [Abstract][Full Text] [Related]
11. Red cell transfusion and alloimmunization in sickle cell disease.
Linder GE; Chou ST
Haematologica; 2021 Jul; 106(7):1805-1815. PubMed ID: 33792218
[TBL] [Abstract][Full Text] [Related]
12. Adverse events of red blood cell transfusions in patients with sickle cell disease.
Rollins MR; Chou ST
Transfus Apher Sci; 2022 Oct; 61(5):103557. PubMed ID: 36064527
[TBL] [Abstract][Full Text] [Related]
13. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
Shih AW; Yan MTS; Elahie AL; Barty RL; Liu Y; Berardi P; Azzam M; Siddiqui R; Parvizian MK; Mcdougall T; Heddle NM; Al-Habsi KS; Goldman M; Cote J; Athale U; Verhovsek MM
Transfus Med; 2020 Aug; 30(4):263-274. PubMed ID: 32432400
[TBL] [Abstract][Full Text] [Related]
14. Indications for RBC Exchange Transfusion in Patients with Sickle Cell Disease: Revisited.
Ballas SK
Ann Clin Lab Sci; 2019 Nov; 49(6):836-837. PubMed ID: 31882437
[TBL] [Abstract][Full Text] [Related]
15. Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients.
Dean CL; Maier CL; Chonat S; Chang A; Carden MA; El Rassi F; McLemore ML; Stowell SR; Fasano RM
Transfusion; 2019 May; 59(5):1698-1705. PubMed ID: 30848512
[TBL] [Abstract][Full Text] [Related]
16. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin PM; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
[TBL] [Abstract][Full Text] [Related]
17. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
[TBL] [Abstract][Full Text] [Related]
18. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
[TBL] [Abstract][Full Text] [Related]
20. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
